Premium
Liver cell dysplasia and hepatocellular carcinoma: Non‐A, non‐B hepatitis, too?
Author(s) -
Cohen Cynthia
Publication year - 1987
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840070531
Subject(s) - hepatocellular carcinoma , cirrhosis , dysplasia , medicine , hepatitis , liver cell , pathology , liver biopsy , hepatitis b virus , biopsy , gastroenterology , hepatitis b , carcinoma , virus , virology
Liver cell dysplasia (LCD) is a premalignant cytologic change of hepatocytes that has been statistically linked to cirrhosis, hepatocellular carcinoma (HCC), and chronic liver disease related to hepatitis B virus. The relationship of LCD to non‐A, non‐B (NANB) hepatitis is currently unknown. We studied liver biopsy and surgical resection specimens from 36 patients with NANB hepatitis, and identified LCD in 17 (42.5%) of 40 specimens, most often associated with cirrhosis. Dysplasia was present in individual hepatocytes, in clusters, and in a distinctive “spreading” pattern of hepatocytes about central veins. Three patients had HCC with a predominant giant cell pattern, as well as LCD. These findings suggest that LCD and HCC should be included among the potential pathologic sequelae of NANB hepatitis.